Health
SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY – Wiley
Click on the article title to read more.
Introduction: COVID-19 is thought to be more frequent and severe in patients with cancer. Lymphoma patients may be especially vulnerable, due to the immunodeficiency and immune dysregulation caused by the lymphoma itself and the antitumor treatments. This…
Continue Reading
-
General23 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News24 hours agoAlleged Gold Coast conman exposed: elderly woman’s life savings vanish in shocking scam
-
Noosa News24 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
Noosa News24 hours agoSam Konstas falls cheaply, Jake Weatherald boosts Ashes hopes on day one of Sheffield Shield